What is Huntingtn Bncshr's earnings per share (EPS)?

Huntingtn Bncshr (HBANM) reported diluted earnings per share of $1.39 for fiscal year 2025. This represents a 13.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Huntingtn Bncshr (HBANM) Financials

HBANM

Trailing 12 months to March 31, 2026

Revenue $8.8B +16.8% YoY

Net Income $2.2B +7.8% YoY

EPS (Diluted) $1.30 -0.8% YoY

Free Cash Flow $2.2B +26.7% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Apr 30, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed Apr 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HBANM SEC filings page.

Huntingtn Bncshr (HBANM) reported $8.8B in revenue over the twelve months to Mar 31, 2026, up 16.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HBANM FY2025 2026-09-05

The dominant mechanic is balance-sheet expansion supporting cash-backed earnings, while asset growth has not lifted returns proportionately.

FY2025 operating cash flow was $2.5B versus net income of $2.2B, indicating reported earnings translated into cash rather than relying mainly on non-cash effects. That conversion improved from FY2024, when operating cash flow was $1.8B against net income of $1.9B.

Assets expanded to $225.1B while reported leverage eased to 0.7x, indicating growth came with a larger balance sheet without a corresponding increase in debt burden. Yet returns remained modest: ROA was 1.0% and ROE was 9.1%, so added scale did not translate proportionately into profitability.

Net margin held near 27.1% in FY2025 despite 10.6% revenue growth, pointing to expansion without broad margin compression. Interest expense remained $4.3B, making funding economics a central feature of the earnings profile.

Financial Health Signals

Financial Health Score 44/100

Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Huntingtn Bncshr's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings

Huntingtn Bncshr earned a return on assets of 1.0% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is up from 0.9% the prior year. Earnings ranks banks on that return over three years, and Huntingtn Bncshr scores 59/100 among other banks.

Growth

Huntingtn Bncshr reported revenue of $8.2B in fiscal year 2025, against $7.4B in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and Huntingtn Bncshr scores 39/100 among other banks.

Capital

Huntingtn Bncshr funded 10.8% of its assets with shareholders' equity at the end of fiscal year 2025, holding $24.3B of equity against $225.1B of assets. Capital ranks banks on that cushion, and Huntingtn Bncshr scores 42/100 among other banks.

Efficiency

Efficiency measures what a bank spends running itself against the revenue that spending brings in, so a lower ratio is the better one. Huntingtn Bncshr scores 59/100 on it among other banks.

Credit Quality

Not available for Huntingtn Bncshr, and counted as zero in the overall score.

Stability

Huntingtn Bncshr reported net income of $2.2B in fiscal year 2025, against $1.9B in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and Huntingtn Bncshr scores 66/100 among other banks.

Piotroski F-Score Partial

6/7

Huntingtn Bncshr passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.12x

For every $1 of reported earnings, Huntingtn Bncshr generates $1.12 in operating cash flow ($2.5B OCF vs $2.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.6B

YoY+34.0%

QoQ+18.4%

5Y CAGR+13.5%

10Y CAGR+13.2%

Huntingtn Bncshr generated $2.6B in revenue in Q1 2026. This represents an increase of 34.0% from the same quarter a year earlier. Against the prior quarter it is up 18.4%.

Net Income

$523.0M

YoY-0.8%

QoQ+0.8%

5Y CAGR-0.3%

10Y CAGR+11.8%

Huntingtn Bncshr reported $523.0M in net income in Q1 2026. This represents a decrease of 0.8% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.

EPS (Diluted)

$0.25

YoY-26.5%

QoQ-16.7%

5Y CAGR-12.2%

10Y CAGR+2.3%

Huntingtn Bncshr earned $0.25 per diluted share (EPS) in Q1 2026. This represents a decrease of 26.5% from the same quarter a year earlier. Against the prior quarter it is down 16.7%.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Free Cash Flow

$400.0M

YoY-12.9%

QoQ-50.6%

10Y CAGR+8.3%

Huntingtn Bncshr generated $400.0M in free cash flow in Q1 2026, representing cash available after capex. This represents a decrease of 12.9% from the same quarter a year earlier. Against the prior quarter it is down 50.6%.

Cash & Debt

$19.2B

YoY+25.3%

QoQ+42.2%

5Y CAGR+17.4%

10Y CAGR+37.1%

Huntingtn Bncshr held $19.2B in cash against $21.6B in long-term debt as of Q1 2026.

Dividends Per Share

$0.15

YoY0.0%

QoQ0.0%

5Y CAGR+0.7%

10Y CAGR+8.3%

Huntingtn Bncshr paid $0.15 per share in dividends in Q1 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

2.03B

YoY+39.1%

QoQ-0.1%

5Y CAGR+14.8%

10Y CAGR+9.8%

Huntingtn Bncshr had 2.03B shares outstanding in Q1 2026. This represents an increase of 39.1% from the same quarter a year earlier. Against the prior quarter it is down 0.1%.

Margins & Returns

Net Margin

20.3%

YoY-7.1pp

QoQ-3.5pp

5Y CAGR-18.6pp

10Y CAGR-2.6pp

Huntingtn Bncshr's net profit margin was 20.3% in Q1 2026, showing the share of revenue converted to profit. This is down 7.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.5 percentage points.

Return on Equity

1.6%

YoY-1.0pp

QoQ-0.5pp

5Y CAGR-2.3pp

10Y CAGR-0.8pp

Huntingtn Bncshr's ROE was 1.6% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Capital Allocation

Share Buybacks

$150.0M

Huntingtn Bncshr spent $150.0M on share buybacks in Q1 2026, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$124.0M

YoY+129.6%

QoQ+5.1%

5Y CAGR+41.3%

10Y CAGR+26.1%

Huntingtn Bncshr invested $124.0M in capex in Q1 2026, funding long-term assets and infrastructure. This represents an increase of 129.6% from the same quarter a year earlier. Against the prior quarter it is up 5.1%.

R&D Spending

Not reported for Q1 2026.

HBANM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HBANM quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$8.8B	$8.2B+10.6%	$7.4B+0.3%	$7.4B+1.5%	$7.3B+21.1%	$6.0B+24.4%	$4.8B+3.2%	$4.7B+3.5%	$4.5B+4.7%	$4.3B+22.4%	$3.5B+17.7%	$3.0B+6.2%	$2.8B+3.7%	$2.7B-3.6%	$2.8B+7.5%	$2.6B
SG&A Expenses	$3.3B	$3.0B+10.9%	$2.7B+6.8%	$2.5B+5.3%	$2.4B+2.8%	$2.3B+38.0%	$1.7B+2.3%	$1.7B+6.1%	$1.6B+2.3%	$1.5B+13.0%	$1.3B+20.2%	$1.1B+7.0%	$1.0B+4.7%	$1.0B+1.4%	$988.2M+10.7%	$892.5M
Interest Expense	$4.5B	$4.3B-5.6%	$4.6B+31.6%	$3.5B+399.6%	$696.0M+682.0%	$89.0M-79.0%	$423.0M-57.2%	$988.0M+30.0%	$760.0M+76.3%	$431.0M+63.9%	$263.0M+60.4%	$164.0M+17.7%	$139.3M-10.7%	$156.0M-29.0%	$219.7M-35.6%	$341.1M
Income Tax	$451.0M	$459.0M+3.6%	$443.0M+7.3%	$413.0M-19.8%	$515.0M+75.2%	$294.0M+89.7%	$155.0M-37.5%	$248.0M+5.5%	$235.0M+13.0%	$208.0M0.0%	$208.0M-5.9%	$221.0M+0.2%	$220.6M-3.0%	$227.5M+12.4%	$202.3M+17.2%	$172.6M
Net Income	$2.2B	$2.2B+14.0%	$1.9B-0.6%	$2.0B-12.8%	$2.2B+72.8%	$1.3B+58.5%	$817.0M-42.1%	$1.4B+1.3%	$1.4B+17.5%	$1.2B+66.6%	$712.0M+2.7%	$693.0M+9.6%	$632.4M-1.4%	$641.3M+1.6%	$631.3M+15.5%	$546.4M
EPS (Basic)	N/A	$1.41+13.7%	$1.24-1.6%	$1.26-14.3%	$1.47+61.5%	$0.91+28.2%	$0.71-45.0%	$1.29+5.7%	$1.22+19.6%	$1.02+41.7%	$0.72-12.2%	$0.82+12.3%	$0.730.0%	$0.73+4.3%	$0.70+16.7%	$0.60
EPS (Diluted)	$1.30	$1.39+13.9%	$1.22-1.6%	$1.24-14.5%	$1.45+61.1%	$0.90+30.4%	$0.69-45.7%	$1.27+5.8%	$1.20+20.0%	$1.00+42.9%	$0.70-13.6%	$0.81+12.5%	$0.720.0%	$0.72+4.3%	$0.69+16.9%	$0.59
Diluted Shares (Avg)	N/A	1.50B+1.9%	1.48B+0.6%	1.47B+0.2%	1.47B+13.9%	1.29B+24.6%	1.03B-2.2%	1.06B-4.5%	1.11B-2.7%	1.14B+23.7%	919M+12.4%	817M-1.9%	833M-1.3%	844M-2.3%	863M-0.5%	868M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$2.6B+34.0%	$2.2B+11.3%	$2.1B+13.9%	$1.9B+7.5%	$1.9B+9.5%	$2.0B+13.5%	$1.9B-0.2%	$1.8B-2.1%
SG&A Expenses	$992.0M+47.8%	$845.0M+18.2%	$757.0M+10.7%	$722.0M+8.9%	$671.0M+5.0%	$715.0M+10.9%	$684.0M+10.0%	$663.0M+8.2%
Interest Expense	$1.2B+12.4%	$1.1B-3.8%	$1.1B-9.1%	$1.1B-6.4%	$1.1B-2.7%	$1.1B+7.8%	$1.2B+27.4%	$1.2B+32.4%
Income Tax	$114.0M-6.6%	$108.0M-20.0%	$133.0M+14.7%	$96.0M-9.4%	$122.0M+41.9%	$135.0M+13600.0%	$116.0M-14.7%	$106.0M-20.9%
Net Income	$523.0M-0.8%	$519.0M-2.1%	$629.0M+21.7%	$536.0M+13.1%	$527.0M+25.8%	$530.0M+118.1%	$517.0M-5.5%	$474.0M-15.2%
EPS (Basic)	$0.26-23.5%	$0.30-11.8%	$0.41+24.2%	$0.35+16.7%	$0.34+30.8%	$0.34+126.7%	$0.33-5.7%	$0.30-16.7%
EPS (Diluted)	$0.25-26.5%	$0.30-11.8%	$0.41+24.2%	$0.34+13.3%	$0.34+30.8%	$0.34+126.7%	$0.33-5.7%	$0.30-14.3%
Diluted Shares (Avg)	1.90B+28.3%	N/A	1.48B+0.5%	1.48B+0.5%	1.48B+0.6%	N/A	1.48B+0.6%	1.47B+0.6%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

HBANM Balance Sheet

HBANM quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$225.1B+10.2%	$204.2B+7.8%	$189.4B+3.5%	$182.9B+5.1%	$174.1B+41.5%	$123.0B+12.9%	$109.0B+0.2%	$108.8B+4.4%	$104.2B+4.5%	$99.7B+40.4%	$71.0B+7.1%	$66.3B+11.5%	$59.5B+5.9%	$56.1B+3.1%	$54.5B
Cash & Equivalents	$13.5B+5.0%	$12.8B+26.8%	$10.1B+51.1%	$6.7B+21.4%	$5.5B-16.3%	$6.6B+463.7%	$1.2B-56.2%	$2.7B+75.8%	$1.5B+9.7%	$1.4B+63.5%	$847.0M-30.6%	$1.2B+22.0%	$1.0B-20.7%	$1.3B0.0%	$1.3B
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$6.0B+7.8%	$5.6B0.0%	$5.6B-0.2%	$5.6B+4.2%	$5.3B+168.8%	$2.0B0.0%	$2.0B+0.1%	$2.0B-0.2%	$2.0B0.0%	$2.0B+194.4%	$677.0M+29.6%	$522.5M+17.6%	$444.3M0.0%	$444.3M0.0%	$444.3M
Total Liabilities	$200.7B+8.8%	$184.4B+8.5%	$170.0B+2.9%	$165.1B+6.7%	$154.7B+40.6%	$110.0B+13.2%	$97.2B-0.5%	$97.7B+4.6%	$93.4B+4.4%	$89.4B+38.8%	$64.4B+7.4%	$60.0B+12.4%	$53.4B+6.0%	$50.4B+2.7%	$49.0B
Long-Term Debt	$17.2B+5.2%	$16.4B+32.1%	$12.4B+28.0%	$9.7B+36.3%	$7.1B-14.9%	$8.4B-15.2%	$9.8B+14.2%	$8.6B-6.3%	$9.2B+10.8%	$8.3B+18.0%	$7.0B+62.4%	$4.3B+76.4%	$2.5B	N/A	N/A
Total Equity	$24.3B+23.3%	$19.7B+2.0%	$19.4B+9.1%	$17.7B-8.1%	$19.3B+48.5%	$13.0B+10.2%	$11.8B+6.2%	$11.1B+2.7%	$10.8B+4.9%	$10.3B+56.3%	$6.6B+4.2%	$6.3B+3.9%	$6.1B+5.4%	$5.8B0.0%	$5.8B
Retained Earnings	$6.4B+22.0%	$5.2B+20.4%	$4.3B+26.4%	$3.4B+55.3%	$2.2B+17.3%	$1.9B-10.1%	$2.1B+53.4%	$1.4B+131.5%	$588.0M+359.0%	-$227.0M+61.8%	-$594.1M+43.5%	-$1.1B+28.9%	-$1.5B+23.3%	-$1.9B+19.2%	-$2.4B

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$285.4B+36.2%	$225.1B+10.2%	$210.2B+4.8%	$207.7B+5.8%	$209.6B+8.3%	$204.2B+7.8%	$200.5B+7.4%	$196.3B+4.1%
Cash & Equivalents	$19.2B+25.3%	$13.5B+5.0%	$12.7B+1.2%	$10.4B-17.4%	$15.3B+25.7%	$12.8B+26.8%	$12.6B+10.1%	$12.5B+13.2%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$9.5B+71.3%	$6.0B+7.8%	$5.5B-0.3%	$5.6B0.0%	$5.6B0.0%	$5.6B0.0%	$5.6B0.0%	$5.6B0.0%
Total Liabilities	$252.8B+33.7%	$200.7B+8.8%	$187.9B+4.5%	$186.8B+5.7%	$189.1B+8.6%	$184.4B+8.5%	$179.9B+7.0%	$176.7B+4.2%
Long-Term Debt	$21.6B+19.3%	$17.2B+5.2%	$17.3B+10.6%	$17.5B+6.1%	$18.1B+21.5%	$16.4B+32.1%	$15.7B+22.1%	$16.5B+11.9%
Total Equity	$32.5B+59.2%	$24.3B+23.3%	$22.2B+8.0%	$20.9B+7.2%	$20.4B+5.8%	$19.7B+2.0%	$20.6B+11.5%	$19.5B+3.9%
Retained Earnings	$6.5B+19.0%	$6.4B+22.0%	$6.1B+24.1%	$5.8B+22.8%	$5.5B+22.3%	$5.2B+20.4%	$4.9B+13.9%	$4.7B+15.5%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities.

HBANM Cash Flow Statement

HBANM quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$2.5B	$2.5B+35.2%	$1.8B-30.9%	$2.7B-34.0%	$4.0B+95.3%	$2.1B+55.9%	$1.3B-15.9%	$1.6B-8.8%	$1.7B-11.7%	$2.0B+60.8%	$1.2B+17.6%	$1.0B+16.2%	$888.8M-12.3%	$1.0B+1.1%	$1.0B-37.2%	$1.6B
Depreciation & Amortization	N/A	$762.0M+22.5%	$622.0M-22.1%	$798.0M+64.9%	$484.0M+23.8%	$391.0M+6.5%	$367.0M-4.9%	$386.0M-21.7%	$493.0M+19.4%	$413.0M+8.7%	$380.0M+11.4%	$341.0M+2.5%	$332.8M+18.2%	$281.5M+2.5%	$274.6M-2.7%	$282.1M
Stock-Based Compensation	N/A	$113.0M+6.6%	$106.0M+9.3%	$97.0M-7.6%	$105.0M-18.6%	$129.0M+67.5%	$77.0M-7.2%	$83.0M+6.4%	$78.0M-15.2%	$92.0M+39.4%	$66.0M+29.4%	$51.0M+16.8%	$43.7M+18.0%	$37.0M+32.8%	$27.9M+41.7%	$19.7M
Capital Expenditures	$337.0M	$267.0M+86.7%	$143.0M+2.1%	$140.0M-34.6%	$214.0M-13.4%	$247.0M+107.6%	$119.0M+11.2%	$107.0M-2.7%	$110.0M-43.3%	$194.0M+61.7%	$120.0M+29.0%	$93.0M+58.0%	$58.9M-42.4%	$102.2M-21.2%	$129.6M-9.8%	$143.8M
Free Cash Flow	$2.2B	$2.2B+30.8%	$1.7B-32.7%	$2.5B-34.0%	$3.8B+110.1%	$1.8B+50.7%	$1.2B-17.9%	$1.5B-9.2%	$1.6B-8.2%	$1.8B+60.7%	$1.1B+16.5%	$940.0M+13.3%	$829.9M-8.9%	$911.0M+4.4%	$872.5M-39.9%	$1.5B
Investing Cash Flow	-$4.3B	-$6.3B+47.6%	-$12.1B-304.4%	-$3.0B+74.2%	-$11.6B-193.0%	-$4.0B+54.1%	-$8.6B-360.3%	-$1.9B+48.8%	-$3.7B+24.7%	-$4.9B-41.2%	-$3.4B+30.1%	-$4.9B+1.5%	-$5.0B-18.0%	-$4.2B-291.5%	-$1.1B+17.0%	-$1.3B
Financing Cash Flow	$5.7B	$4.5B-65.3%	$13.0B+245.3%	$3.8B-57.0%	$8.8B+959.7%	$827.0M-93.5%	$12.7B+1162.6%	-$1.2B-138.8%	$3.1B+1.4%	$3.0B+10.1%	$2.8B-21.4%	$3.5B-18.8%	$4.3B+46.2%	$3.0B+1202.4%	$227.7M+1134.9%	-$22.0M
Dividends Paid	$930.0M	$908.0M+0.6%	$903.0M+0.3%	$900.0M+0.3%	$897.0M+19.6%	$750.0M+22.1%	$614.0M+2.8%	$597.0M+16.1%	$514.0M+47.3%	$349.0M+42.4%	$245.0M+26.9%	$193.0M+15.6%	$166.9M+10.8%	$150.6M-11.1%	$169.3M+83.3%	$92.4M
Share Buybacks	N/A	N/A	N/A	$0	$0-100.0%	$650.0M+606.5%	$92.0M-79.1%	$441.0M-53.0%	$939.0M+261.2%	$260.0M	$0-100.0%	$252.0M-24.6%	$334.4M+167.6%	$125.0M	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	$524.0M+2.1%	$928.0M-16.8%	$487.0M+939.7%	$554.0M+86.5%	$513.0M+6.4%	$1.1B+24.2%	-$58.0M-105.8%	$297.0M-52.9%
Depreciation & Amortization	$191.0M-8.6%	$190.0M	$175.0M+32.6%	$188.0M	$209.0M+10.0%	N/A	$132.0M-38.3%	N/A
Stock-Based Compensation	$45.0M+114.3%	N/A	N/A	N/A	$21.0M+5.0%	N/A	N/A	N/A
Capital Expenditures	$124.0M+129.6%	$118.0M+337.0%	$41.0M-2.4%	$54.0M+28.6%	$54.0M+68.8%	$27.0M-55.0%	$42.0M+82.6%	$42.0M+31.3%
Free Cash Flow	$400.0M-12.9%	$810.0M-25.6%	$446.0M+546.0%	$500.0M+96.1%	$459.0M+2.0%	$1.1B+29.8%	-$100.0M-110.2%	$255.0M-57.4%
Investing Cash Flow	-$135.0M+93.7%	-$1.4B+70.0%	-$266.0M+90.8%	-$2.5B-13.8%	-$2.1B+5.0%	-$4.8B-44.6%	-$2.9B-299.5%	-$2.2B-287.8%
Financing Cash Flow	$5.3B+29.3%	$1.3B-67.8%	$2.2B-27.5%	-$3.0B-233.1%	$4.1B+7.0%	$3.9B+255.7%	$3.0B+242.7%	$2.3B+308.0%
Dividends Paid	$248.0M+9.7%	$228.0M+0.9%	$227.0M+0.4%	$227.0M+0.9%	$226.0M0.0%	$226.0M0.0%	$226.0M+0.4%	$225.0M+0.4%
Share Buybacks	$150.0M	N/A	N/A	N/A	$0	N/A	N/A	N/A

HBANM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HBANM quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	27.1%+0.8pp	26.3%-0.2pp	26.5%-4.3pp	30.9%+9.2pp	21.6%+4.7pp	17.0%-13.3pp	30.2%-0.7pp	30.9%+3.4pp	27.5%+7.3pp	20.2%-2.9pp	23.2%+0.7pp	22.4%-1.1pp	23.6%+1.2pp	22.4%+1.6pp	20.8%
Return on Equity	9.1%-0.7pp	9.8%-0.3pp	10.1%-2.5pp	12.6%+5.9pp	6.7%+0.4pp	6.3%-5.7pp	12.0%-0.6pp	12.6%+1.6pp	11.0%+4.1pp	6.9%-3.6pp	10.5%+0.5pp	10.0%-0.5pp	10.5%-0.4pp	10.9%+1.5pp	9.5%
Return on Assets	1.0%0.0pp	0.9%-0.1pp	1.0%-0.2pp	1.2%+0.5pp	0.7%+0.1pp	0.7%-0.6pp	1.3%0.0pp	1.3%+0.1pp	1.1%+0.4pp	0.7%-0.3pp	1.0%0.0pp	0.9%-0.1pp	1.1%0.0pp	1.1%+0.1pp	1.0%
Debt-to-Equity	0.71-0.1x	0.83+0.2x	0.64+0.1x	0.55+0.2x	0.37-0.3x	0.64-0.2x	0.83+0.1x	0.78-0.1x	0.850.0x	0.81-0.3x	1.07+0.4x	0.69+0.3x	0.40-8.3x	8.72+0.2x	8.49
Asset Turnover	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.030.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.050.0x	0.050.0x	0.05
FCF Margin	27.1%+4.2pp	22.9%-11.3pp	34.2%-18.4pp	52.6%+22.3pp	30.3%+5.3pp	25.0%-6.4pp	31.4%-4.4pp	35.8%-5.0pp	40.8%+9.7pp	31.1%-0.3pp	31.4%+2.0pp	29.5%-4.1pp	33.5%+2.6pp	31.0%-24.4pp	55.4%

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Net Margin	20.3%-7.1pp	23.9%-3.3pp	29.5%+1.9pp	27.7%+1.4pp	27.5%+3.6pp	27.1%+13.0pp	27.6%-1.6pp	26.3%-4.1pp
Return on Equity	1.6%-1.0pp	2.1%-0.6pp	2.8%+0.3pp	2.6%+0.1pp	2.6%+0.4pp	2.7%+1.4pp	2.5%-0.5pp	2.4%-0.6pp
Return on Assets	0.2%-0.1pp	0.2%0.0pp	0.3%0.0pp	0.3%0.0pp	0.3%0.0pp	0.3%+0.1pp	0.3%0.0pp	0.2%-0.1pp
Debt-to-Equity	0.66-0.2x	0.71-0.1x	0.780.0x	0.830.0x	0.89+0.1x	0.83+0.2x	0.76+0.1x	0.84+0.1x
Asset Turnover	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x
FCF Margin	15.6%-8.4pp	37.3%-18.4pp	20.9%+26.2pp	25.8%+11.7pp	23.9%-1.7pp	55.7%+7.0pp	-5.3%-57.3pp	14.1%-18.3pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Huntingtn Bncshr HBANM	FY2025	$8.2B	$2.2B	27.1%	N/A	44/100
Huntington Bancshares Inc HBANL	FY2025	$8.2B	$2.2B	27.1%	N/A	44/100
Huntington Bancs HBANP	FY2025	$8.2B	$2.2B	27.1%	N/A	44/100
Wesbanco WSBCP	FY2025	$1.3B	$223.1M	17.5%	N/A	65/100
Bridgewater Banc BWBBP	FY2025	$143.4M	$46.1M	32.1%	N/A	60/100
Mainstreet Bancshares Inc MNSBP	FY2025	$135.6M	$15.6M	11.5%	N/A	49/100

Where Huntingtn Bncshr Ranks

Frequently Asked Questions

What is Huntingtn Bncshr's annual revenue?

Huntingtn Bncshr (HBANM) reported $8.2B in total revenue for fiscal year 2025. This represents a 10.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Huntingtn Bncshr's revenue growing?

Huntingtn Bncshr (HBANM) revenue grew by 10.6% year-over-year, from $7.4B to $8.2B in fiscal year 2025.

Is Huntingtn Bncshr profitable?

Yes, Huntingtn Bncshr (HBANM) reported a net income of $2.2B in fiscal year 2025, with a net profit margin of 27.1%.

How much debt does Huntingtn Bncshr have?

As of fiscal year 2025, Huntingtn Bncshr (HBANM) had $13.5B in cash and equivalents against $17.2B in long-term debt.

What is Huntingtn Bncshr's net profit margin?

Huntingtn Bncshr (HBANM) had a net profit margin of 27.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Huntingtn Bncshr pay dividends?

Yes, Huntingtn Bncshr (HBANM) paid $0.62 per share in dividends during fiscal year 2025.

What is Huntingtn Bncshr's return on equity (ROE)?

Huntingtn Bncshr (HBANM) has a return on equity of 9.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Huntingtn Bncshr's free cash flow?

Huntingtn Bncshr (HBANM) generated $2.2B in free cash flow during fiscal year 2025. This represents a 30.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Huntingtn Bncshr's operating cash flow?

Huntingtn Bncshr (HBANM) generated $2.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Huntingtn Bncshr's total assets?

Huntingtn Bncshr (HBANM) had $225.1B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Huntingtn Bncshr's capital expenditures?

Huntingtn Bncshr (HBANM) invested $267.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Huntingtn Bncshr have outstanding?

Huntingtn Bncshr (HBANM) had 2.03B shares outstanding as of fiscal year 2025.

What is Huntingtn Bncshr's debt-to-equity ratio?

Huntingtn Bncshr (HBANM) had a debt-to-equity ratio of 0.71 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Huntingtn Bncshr's return on assets (ROA)?

Huntingtn Bncshr (HBANM) had a return on assets of 1.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Huntingtn Bncshr's Piotroski F-Score?

Huntingtn Bncshr (HBANM) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Huntingtn Bncshr's earnings high quality?

Huntingtn Bncshr (HBANM) has an earnings quality ratio of 1.12x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Huntingtn Bncshr?

Huntingtn Bncshr (HBANM) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.